Showing posts with label Medcrave. Show all posts
Showing posts with label Medcrave. Show all posts

Sunday, April 26, 2020

Flaky Journal Prices

Some flaky journals are so anxious for content that they will lower their advertised fees or publish for free. That is what some authors of spoofs have discovered after submitting absurd papers.

"Neuroskeptic" at Discover Magazine prepared a "spoof manuscript about 'midi-chlorians' – the fictional entities which live inside cells and give Jedi their powers in Star Wars." It was filled with "references to the galaxy far, far away, and submitted ... to nine journals under the names of Dr Lucas McGeorge and Dr Annette Kin." The author found that

The American Journal of Medical and Biological Research (SciEP) accepted the paper, but asked for a $360 fee, which I didn’t pay. Amazingly, three other journals not only accepted but actually published the spoof. [T]he International Journal of Molecular Biology: Open Access (MedCrave), Austin Journal of Pharmacology and Therapeutics (Austin) and American Research Journal of Biosciences (ARJ). I hadn’t expected this, as all those journals charge publication fees, but I never paid them a penny. \1/
A biologist, threatening to withdraw a paper on "What Up with Birds?" and send it to Nature, negotiated a $1,600 charge down to $1,027, to $99, and then, pleading "financial crisis," to $0. The journal manager reported that he had "done session with our Higher Authorities" to obtain this one-time waiver. \2/ The abstract of the article, which appeared this month, reads as follows:
Many people wonder: what’s the deal with birds? This is a common query. Birds are pretty weird. I mean, they have feathers. WTF? Most other animals don’t have feathers. To investigate this issue, I looked at some birds. I looked at a woodpecker, a parrot, and a penguin. They were all pretty weird! In conclusion, we may never know the deal with birds, but further study is warranted.
The paper and Iris's alleged peer review are discussed in other blog postings. \3/

UPDATE 5/9/20: On ResearchGate today, Malek Alghdeir commented that "I was invited to publish a chapter in a book by IntechOpen. Then asked me to pay 1400 £! firstly, the editor of my chapter suggests a great discount, but after that, they accepted to publish my chapter free."

NOTES
  1. Neuroskeptic, Predatory Journals Hit By 'Star Wars' Sting, Discover, July 22, 2017 5:57 AM, https://www.discovermagazine.com/mind/predatory-journals-hit-by-star-wars-sting
  2. https://twitter.com/evornithology/status/1224775369783435264?s=20 (hilarious Twitter thread)
  3. Iris Publishers Releases the World's First Quantification of the Deal with Birds, Flaky Academic Journals, Apr. 26, 2020; Ryan F. Mandelbaum, Sketchy Science Journal Publishes Article Titled 'What's the Deal With Birds?', Gizmodo, Apr. 17, 2020 4:40PM, https://gizmodo.com/sketchy-science-journal-publishes-article-titled-whats-1842924936/amp

Monday, April 10, 2017

The Manuscripts of MedCrave

The MedCrave Publishing Group's About Us page contains the vacuous hyperbole typical of journals that are best avoided. Here we learn that MedCrave is
dedicated to make original valuable scientific content available freely to the global population. ... amazed by science and its wonderful forms and we now bring this beauty to you too. ... a collection of ... works of pure significance. ... relevant to science ... open for all interested members around the globe ... .
Not only that,but
The manuscripts of MedCrave have overcome all the barriers that lay in the way of knowledge.
With the insight of a Chinese fortune cookie, MedCrave "considers the will to tear up your ignorance as the best price you could pay" and gushes that "there is no best price for knowledge except the will to learn." As to what one might learn, well, it could be anything "from the traditional divisions to contemporary works."

It could even be a faux study of "uromycitisis poisoning" -- a disease created for an episode of Seinfeld -- submitted by a nonexistent "Arthur Vandelay Urological Research Institute" to MedCrave's Urology & Nephrology Open Access Journal. It took three days for the journal to complete its favorable peer review of an article with a references to nonexistent sources such as a putative New York Times report that "New Public Urination Passes Approved for Uromycitisis Sufferers." The author of the uromycitis article describes the incident in The Scientist.

Medcrave considers itself "one of the finest Online Publishing Groups" and has a scrolling banner of "NIH funded and indexed articles." I clicked on three of them. None were published by MedCrave. Another journal proudly proclaims that it will not "risk your creativity for the sake of the journal’s fame or quality." It will publish "any kind of article" "in the scope of science " "in any stage of the research in any [style]."

The domain medcraveonline.org is registered to Sabrina M, Boardwalk Cir, Bartlesville Oklahoma 74006, +1.9182080288, sabrinamyers07@gmail.com.
Email
  • From: Authors Journal
    Sent: Sep 15 at 7:25 AM
    Subject: Publication Rights to Authors: Authors Journal
    Greetings from MedCrave Group! Hope you are doing well. We are very glad to announce that a new journal Authors Journal is launched. The only aim of this journal is to protect your creativity. Your manuscript will not be peer reviewed. We do not risk your creativity for the sake of the journal’s fame or quality. All submissions will be published as soon as the author’s identities are checked and the content of the manuscript is in the scope of science and it does not violate the law of related countries. The quality of the papers in the journal is ensured by author’s names and affiliations.
    We kindly request you to submit any kind of article in any stage of the research in your own preferred style. Please let us know if you have any suggestions to help us to serve you better. This is the Authors Journal, your own journal.
    Best Regards, Helen White, Manager & Co-Founder, Authors Journal, Tel: +1-918-208-0288, E-mail: aj@medcraveonline.org
    *PS: For our ideologies and any concerns about the Journal, kindly contact us. We will provide you with one time password to verify our Journal strategy.